cagrilintide starting dose Coadministered and Semaglutide in Adults with Overweight or Obesity Cagrilintide Dosage: Doctor Explains Dosing

Reconstituted stability: 14 days at 2-8C in copper-free polypropylene containers, protected from light

4 wks @ 250 mcg/day: ~1 vial (20 mg) 4 wks @ 500 mcg/day: ~1 vial (20 mg), leftover On 10 mg vials: roughly double the vial count Insulin Syringes (U-100, 1 mL) Per injection: 1 syringe 4 weeks (once daily): ~28 syringes 8 weeks (once daily): ~56 syringes Bacteriostatic Water (10 mL bottles) Use ~3.0 mL per blend vial for reconstitution

Amylin replacement with pramlintide as an adjunct to insulin therapy improves long-term glycaemic and weight control in Type 1 diabetes mellitus: a 1-year, randomized controlled trial

Contraindications: Not for use in individuals with cancer, during pregnancy/breastfeeding, or those with known hypersensitivity to peptide components

CJC-1295 (without DAC/Mod GRF 1-29): Shorter-acting version for more precise control of GH pulses

After reconstitution with bacteriostatic water: store at 4C, use within 28 days